H. Krumholz

发表

Cause or Effect? Enzyme Deficit in Hypertensive Lungs

H. Krumholz, 1995 .

Diet Pills and Heart Disease.

H. Krumholz, 1997 .

Atrial Fibrillation in Women

H. Krumholz, 1998 .

How Prevalent Is Mitral-Valve Prolapse?

H. Krumholz, 1999 .

Sex-Specific Normal Values for Cardiac Echo

H. Krumholz, 1997 .

Left Ventricular Dilatation Predicts Heart Failure.

H. Krumholz, 1997 .

Beta-Blockers for Heart Failure: A Step Closer

H. Krumholz, 1996 .

Antihypertensive Medication and Diabetes

H. Krumholz, 2000 .

Lifestyle and Primary Prevention of CHD in Women

H. Krumholz, 2000 .

ACE Genes Do Not Accurately Predict Risk of Ischemia

H. Krumholz, 1995 .

Organization to Assess Strategies for Ischemic Syndromes (OASIS).

H. Krumholz, 1997 .

Stroke After MI.

H. Krumholz, 1997 .

Cost Effectiveness of t-PA, Streptokinase

H. Krumholz, 1995 .

Pravastatin Benefits Hypercholesterolemic but Healthy Men

H. Krumholz, 1995 .

VANQWISH Shows Cath Not Beneficial for Non-Q-Wave MI.

H. Krumholz, 1998 .

Risk Factors and Plaque Morphology in CAD.

H. Krumholz, 1997 .

Do Patients with Contraindications Benefit from Beta-Blockers After MI?

H. Krumholz, 1998 .

Optimal Range for Anticoagulation in Atrial Fibrillation

H. Krumholz, 1995 .

Optimal Range for Anticoagulating Mechanical Valves

H. Krumholz, 1995 .

Lowest Effective INR for Atrial Fibrillation

H. Krumholz, 1996 .

Swan Song for Beta Carotene . .

H. Krumholz, 1996 .

Growth Hormone for Cardiomyopathy Shows Promise

H. Krumholz, 1996 .

Clopidogrel Adds Benefit to Aspirin for ACS Patients

H. Krumholz, 2001 .

Intensive glucose control and cardiovascular outcomes

S. Inzucchi, K. Lipska, M. Kosiborod, 2009, The Lancet.

ICDs Benefit Survivors of Near-Fatal VF

H. Krumholz, 1998 .

Better Health Habits Reduce Disability.

H. Krumholz, 1998 .

Interventional Cardiology in Europe.

H. Krumholz, 1996 .

Carvedilol for Severe Heart Failure

H. Krumholz, 2001 .

The Use of Troponins T and I in Emergency Room Triage

H. Krumholz, 1998 .

Trends in CHD Mortality and Incidence of MI, 1987 to 1994.

H. Krumholz, 1998 .

Acute Cardiac Ischemia Often Missed in the ED

H. Krumholz, 2000 .

Cardiologists Achieve Better Patient Outcomes.

H. Krumholz, 1997 .

Sudden Death After a Blow to the Chest.

H. Krumholz, 1998 .

Coronary Artery Calcification in Dialysis Patients

H. Krumholz, 2000 .

Hyperinsulinemia and Heart Disease

H. Krumholz, 1996 .

Risk Factors for Carotid Stenosis.

H. Krumholz, 1997 .

Pravastatin Lowers Risk in Patients with Average Cholesterol Levels.

H. Krumholz, 1996 .

DASH Minus Sodium Equals Lower Blood Pressure

H. Krumholz, 2001 .

Patient's Race and Sex Influence MD Recommendations for Cardiac Care

H. Krumholz, 1999 .

MI Care in the U.S. and Canada: Outcomes at One Year

H. Krumholz, 1995 .

Risk Factors for Nonhemorrhagic Stroke in Thrombolized AMI Patients

H. Krumholz, 1998 .

Risk Factors for Nonhemorrhagic Stroke in AMI.

H. Krumholz, 1998 .

Adverse Neurologic Events After CABG.

H. Krumholz, 1997 .

Good Long-Term Prognosis for Fulminant Myocarditis

H. Krumholz, 2000 .

Optimal Duration of Anticoagulation for Thromboembolism

H. Krumholz, 1995 .

Thrombotic Thrombocytopenic Purpura and Clopidogrel

H. Krumholz, 2000 .

Pacemaker Choice in the Elderly.

H. Krumholz, 1998 .

ICDs for Patients with HCM

H. Krumholz, 2000 .

Abciximab Beats Tirofiban in PCI: The TARGET Trial

H. Krumholz, 2001 .

Stent for Acute Aortic Dissection

H. Krumholz, 1999 .

For Renal Artery Stenosis, Angioplasty Is No Better Than Drug Therapy

H. Krumholz, 2000 .

Iron and Atherosclerosis Risk.

H. Krumholz, 1998 .

Iron and Atherosclerosis

H. Krumholz, 1998 .

Wall Thickening Predicts Sudden Death in Hypertrophic Cardiomyopathy

H. Krumholz, 2001 .

Wall Thickening Predicts Sudden Death in HCM

H. Krumholz, 2000 .

Endothelin-Receptor Antagonist for Hypertension.

H. Krumholz, 1998 .

Inhaled Iloprost for Pulmonary Hypertension

H. Krumholz, 2000 .

Familial Amyloidosis in Blacks.

H. Krumholz, 1997 .

Surgery for MR Due to Flail Leaflet.

H. Krumholz, 1996 .

Racial Differences and Prognosis with LV Dysfunction

H. Krumholz, 1999 .

Lowering Cholesterol Improves Function of Endothelium

H. Krumholz, 1995 .

Women with Angina Get Fewer Referrals for Procedures

H. Krumholz, 1996 .

Complex Coronary Plaques Herald Poor Prognosis in Patients with Acute MI

H. Krumholz, 2000 .

Protective Effect of Eating Fish Not Confirmed

H. Krumholz, 1995 .

Nesiritide Beneficial for CHF, But Not Better Than Standard Therapy

H. Krumholz, 2000 .

Fewer Cardiovascular Risk Factors Equal Lower Long-Term Cost.

H. Krumholz, 1998 .

Vitamin E Not Beneficial

H. Krumholz, 2000 .

Low-Molecular-Weight Heparin Reduces Risk of Thrombocytopenia

H. Krumholz, 1995 .

Small Treatment Differences After Acute MI for Men and Women

H. Krumholz, 2000 .

Warfarin Effective for Antiphospholipid-Antibody Syndrome

H. Krumholz, 1995 .

Elevated C-Reactive Protein Predicts Long-Term Cardiac-Related Mortality in ACS

H. Krumholz, 2001 .

Gap-Junction Genes and Heart Deformities

H. Krumholz, 1995 .

Gender and CHD Mortality Revisited: A Population View

H. Krumholz, 1998 .

CABG Beats Angioplasty for Diabetics

H. Krumholz, 2001 .

CABG Better Than Angioplasty for Diabetics

H. Krumholz, 2000 .

Duration of Anticoagulation for Recurrent PE or DVT.

H. Krumholz, 1997 .

AV Node Ablation and Pacemakers for Drug-Refractory AF

H. Krumholz, 2001 .

Cardiovascular Disease in Europe.

H. Krumholz, 1997 .

Lipoprotein-Associated Phospholipase A

H. Krumholz, 2001 .

Overestimation of genetic risks owing to small sample sizes in cardiovascular studies

H. Krumholz, C. Coffey, H. Krumholz, 2003, Clinical genetics.

Amlodipine for Heart Failure.

H. Krumholz, 1996 .

PTCA vs. CABG for Multivessel Coronary Artery Disease

H. Krumholz, 1995 .

Hirudin, Hirulog, and Restenosis

H. Krumholz, 1995 .

CABG and PTCA: Similar Mortality for Women and Men

H. Krumholz, 1998 .

Reteplase Offers No Advantage Over Alteplase.

H. Krumholz, 1997 .

GUSTO IIb: Angioplasty vs. t-PA in AMI.

H. Krumholz, 1997 .

Advantage of Low-Molecular-Weight Heparin.

H. Krumholz, 1997 .

Hemostatic Factors May Predict MI or Sudden Death

H. Krumholz, 1995 .

Hematocrit in Cardiac Patients Receiving Hemodialysis.

H. Krumholz, 1998 .

CPR with Chest Compression Alone Beneficial

H. Krumholz, 2000 .

Antidepressants for Smoking Cessation

H. Krumholz, 1997 .

Bupropion Boosts Smoking Cessation Rates

H. Krumholz, 1999 .

Sleep-Disordered Breathing Associated with Hypertension

H. Krumholz, 2000 .

Genotype and Risk of Death in HCM

H. Krumholz, 1995 .

Thyroid Does Not Help CABG Outcome

H. Krumholz, 1996 .

Hormone Therapy and Endothelium Function

H. Krumholz, 1998 .

PTCA Improves Outcome in RV Infarction.

H. Krumholz, 1998 .

Gender and Angioplasty Outcomes

H. Krumholz, 1996 .

Ordinary Patients and Clinical Trial Subjects Are Different

H. Krumholz, 1995 .

Amiodarone Beneficial for Atrial Fibrillation

H. Krumholz, 2000 .

Late Cardiac Effects from Doxorubicin More Likely in Women

H. Krumholz, 1995 .

Factor VII Gene and Risk for MI

H. Krumholz, 2000 .

Fish -- Good For the Heart.

H. Krumholz, 1997 .

Prognostic Factors for Severe, Asymptomatic Aortic Stenosis

H. Krumholz, 2000 .

Initiation of Atrial Fibrillation and Its Prevention.

H. Krumholz, 1998 .

Desmin and Cardiomyopathy

H. Krumholz, 2000 .

More Evidence for the Genetic Basis of Dilated Cardiomyopathy

H. Krumholz, 2000 .